Following a heart attack, the parts of the heart muscle that die do not regenerate into new heart tissue and instead are replaced by scar tissue. Using rodent models, researchers at Baylor College of Medicine are looking ...
Apr 17, 2018
0
3
According to the Centers for Disease Control and Prevention, more than 16 percent of adults in the United States have been diagnosed with chronic rhinosinusitis, or CRS—commonly defined as a sinus infection and inflammation ...
Mar 28, 2018
0
4
Survivors of childhood cancer are at increased risk of suffering prematurely from cardiovascular disease in adulthood, according to a study published today (Friday) in the European Heart Journal.
Mar 8, 2018
0
7
Researchers face a number of challenges when conducting a clinical study.1 Investigators spend considerable time and money recruiting and screening viable participants. If recruitment takes too long, important studies can ...
Mar 6, 2018
0
4
A study of patients with obstructive sleep apnea (OSA) suggests that non-adherence to continuous positive airway pressure (CPAP) therapy is significantly associated with increased 30-day hospital readmissions.
Feb 22, 2018
0
6
The heart derives its energy primarily from fatty acids. However, if a metabolic shift to other energy sources takes place, this can result in congestive heart failure, scientists from the German Cancer Research Center (DKFZ) ...
Jan 24, 2018
0
7
Older adults are more likely than younger adults to develop critical illnesses that require hospitalization and intensive care. These illnesses include severe pneumonia and other serious respiratory conditions, congestive ...
Jan 17, 2018
0
4
With a mortality rate estimated at 10%, the life-threatening condition known as thyroid storm (TS) demands rapid diagnosis and treatment and can benefit from new evidence-based guidelines for TS developed by researchers in ...
Jan 2, 2018
0
2
(HealthDay)—The odds of carotid artery stenting (CAS) have increased in the post-Carotid Revascularization Endarterectomy vs Stenting Trial (CREST) era, despite safety concerns for patients older than 70 years, according ...
Dec 4, 2017
0
1
(HealthDay)—Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers, the agency said Friday in a news release.
Dec 4, 2017
0
0
